Regeneron Pharmaceuticals REGN Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's share buybacks?
- Regeneron Pharmaceuticals (REGN) reported share buybacks of $794.3M in Q1 2026.
- How has Regeneron Pharmaceuticals's share buybacks changed year-over-year?
- Regeneron Pharmaceuticals's share buybacks decreased by 23.7% year-over-year, from $1.04B to $794.3M.
- What is the long-term trend for Regeneron Pharmaceuticals's share buybacks?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's share buybacks has grown at a 20.2% compound annual growth rate (CAGR), from $1.65B to $3.44B.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.